Press Releases

    • May 19, 2020

    Nemaura Medical 2020 Stock Incentive Plan Approved at Annual General Meeting

    Loughborough, England, May 19, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    May 11, 2020

    Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device

    sugarBEAT® was developed as a viable, flexible, and cost-effective alternative to invasive continuous glucose monitors (“CGM”), and the company...

    Read more
    May 5, 2020

    Nemaura Medical Announces Interview with CEO to Air on May 11

    Loughborough, England, May 5, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    April 21, 2020

    Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy

    Loughborough, England, April 21, 2020 — Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    April 1, 2020

    Nemaura Plans To Launch Body-Worn Continuous Temperature Monitor (CTM) to Track Fever Caused by Viral Infections such as COVID-19

    BEAT® platform is planned to be extended to conditions requiring continuous temperature monitoring including viral infections and poor blood...

    Read more
    March 30, 2020

    Nemaura to launch new digital brand proBEAT™ in the USA, Targeting a Market of over 100 Million potential users with its Prescription-Free Consumer Wellness Glucose Monitoring Device and Digital Healthcare Subscription Service

      Loughborough, England, March 30, 2020 — Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    Read more
    March 10, 2020

    Nemaura Medical enters into multiple verbal non-binding agreements for its sugarBEAT® platform

    sugarBEAT® strategic global partnership(s) a step closer as Nemaura Medical enters into multiple verbal non-binding agreements Loughborough, England, March...

    Read more
    March 3, 2020

    Nemaura Medical Launches sugarBEAT® App on Play Store Ahead of its Planned Commercial Launch of BEAT®diabetes Subscription Service

    sugarBEAT® App is now available on Play Store with iOS app planned to follow, ahead of the planned BEAT®diabetes...

    Read more
    February 25, 2020

    Nemaura Medical Plans Head-to-Head Study with Major Glucose Monitoring System

    Studies planned to compare sugarBEAT® and major continuous glucose monitor sensor, seeking to position sugarBEAT® as both a possible...

    Read more
    February 11, 2020

    Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019

    Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) — – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company...

    Read more